0001

Anhui Fengyuan Pharmaceutical Co., Ltd. (000153)

Market Closed
15 Jan, 06:57
XSHE XSHE
¥
5. 88
-0.04
-0.68%
¥
2.84B Market Cap
15.35 P/E Ratio
0.6% Div Yield
5,668,540 Volume
0 Eps
¥ 5.92
Previous Close
Day Range
5.84 5.94
Year Range
4.89 9.22

Summary

000153 closed today lower at ¥5.88, a decrease of 0.68% from yesterday's close, completing a monthly decrease of -4.55% or ¥0.28. Over the past 12 months, 000153 stock lost -4.55%.
000153 is not paying dividends to its shareholders.
The last earnings report, released on May 22, 2024, exceeded the consensus estimates by 0.14%. On average, the company has surpassed earnings expectations by 0.1%, based on the last three reports.
Anhui Fengyuan Pharmaceutical Co., Ltd. has completed 1 stock splits, with the recent split occurring on Jun 07, 2024.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XSHE (CNY).
Want to track 000153 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

000153 Chart

FAQ

What Is the Anhui Fengyuan Pharmaceutical Co., Ltd.(000153) Stock Price Today?

The 000153 stock price today is ¥5.88.

What Stock Exchange Does Anhui Fengyuan Pharmaceutical Co., Ltd. Trade On?

Anhui Fengyuan Pharmaceutical Co., Ltd. is listed and trades on the XSHE.

What Is the Stock Symbol for Anhui Fengyuan Pharmaceutical Co., Ltd.?

The stock symbol for Anhui Fengyuan Pharmaceutical Co., Ltd. is "000153".

Does Anhui Fengyuan Pharmaceutical Co., Ltd. Pay Dividends? What's The Current Dividend Yield?

000153 is not paying dividends to its shareholders.

What Is the Anhui Fengyuan Pharmaceutical Co., Ltd. Market Cap?

As of today, Anhui Fengyuan Pharmaceutical Co., Ltd. market cap is 2.84B.

Did Anhui Fengyuan Pharmaceutical Co., Ltd. had any splits?

Anhui Fengyuan Pharmaceutical Co., Ltd. had 1 splits and the recent split was on Jun 07, 2024.

Anhui Fengyuan Pharmaceutical Co., Ltd. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Mr. Tianle Ru CEO
XSHE Exchange
CNE0000014X5 ISIN
CN Country
4,670 Employees
- Last Dividend
7 Jun 2024 Last Split
7 Sep 2000 IPO Date

Overview

Anhui Fengyuan Pharmaceutical Co., Ltd., established in 1997 and headquartered in Hefei, China, is a prominent player in the pharmaceutical industry. The company is dedicated to the research and development, production, and sales of a wide range of pharmaceutical products. Its diverse portfolio includes biopharmaceuticals, chemical pharmaceuticals, Chinese patent medicines, Chinese herbal decoction pieces, and Active Pharmaceutical Ingredients (APIs). With a strong focus on the domestic market, Anhui Fengyuan Pharmaceutical has also made significant inroads in international markets, exporting products to Africa, Southeast Asia, Central Asia, Europe, and various other regions worldwide.

Products and Services

  • Gynecology: The company develops and offers a variety of pharmaceutical solutions tailored for women’s health, addressing conditions specific to the female reproductive system.
  • Respiratory System: Offering treatments aimed at alleviating and treating respiratory conditions, ensuring better breathing and lung health.
  • Hormonal: An array of products designed to balance and treat hormonal disorders, supporting endocrine health.
  • Antipyretic Analgesic: Medications focused on relieving fever and pain, catering to symptomatic relief for a variety of conditions.
  • Mental Class: A diverse range of drugs aimed at treating mental and neurological disorders, promoting mental health and well-being.
  • Antiviral Class: Dedicated to combating viral infections, these products are critical in the treatment and management of viral diseases.
  • Antibiotic Class: This category includes drugs designed to fight bacterial infections, essential in both acute and chronic disease management.
  • Oral Anesthetic: Products that provide local anesthesia, particularly used in dental procedures and pain relief in the oral cavity.
  • Masks Class: Besides pharmaceuticals, the company also ventures into medical supplies like masks, contributing to infection control.
  • Urinary: A range of products focused on urinary tract health, addressing conditions such as infections and bladder issues.
  • Water Electrolyte Balance: Solutions that help in maintaining the body’s electrolyte balance, crucial for metabolic functions and hydration.
  • Digestive System: Products designed to treat and manage digestive system disorders, promoting gastrointestinal health.
  • Cardiovascular Class: Medications aimed at treating cardiovascular diseases, improving heart health and circulation.
  • Yinpian Class: Traditional Chinese medicine pieces, emphasizing the use of natural herbs and components for therapeutic purposes.
  • Nutrition and Metabolism: Products that support nutritional well-being and metabolic health, addressing deficiencies and metabolic disorders.
  • Raw Material Drugs: Anhui Fengyuan Pharmaceutical also supplies Active Pharmaceutical Ingredients (APIs), catering to the broader pharmaceutical manufacturing sector.

Contact Information

Address: No.16 Dalian Road, Hefei, China
Phone: 86 551 6484 6195